microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ﻿ acrysof® iq toric iols  myalconcom  back to resources for eye care and health care professionals contact us print cataract equipment centurion® vision system infiniti® vision system lensx® laser system luxor™ ophthalmic microscope cataract refractive diagnostics cataract iols acrysof® iq restor® multifocal iols acrysof® iq toric iol acrysof® iq monofocal iol ultrasert™ preloaded delivery system acrysof® iq iol vision simulator cataract disposables bss plus® irrigating solution ophthalmic viscosurgical devices ovds refractive technology surgical diagnostics devices wavelight® refractive suite wavelight® allegretto wave® eyeq laser videos and resources wavelight® tcat study surgical glaucoma express® glaucoma filtration device vitreoretinal surgery vitreoretinal surgical constellation® vision system alcon® mivs portfolio grieshaber® dsp instrumentation purepoint® laser retinal stabilizing adjuncts tools  resources iol calculations label information us technical service reimbursement services “find an eye surgeon” profile mri compatible products natural rubber latex product list alcon medical education grants medical missions cataract iols acrysof® iq restor® multifocal iols overview and key features design comparison visual performance patient profile specifications acrysof® iq restor®  d iol diffractive optic design data support specifications acrysof® iq restor®  d iol diffractive optic design data support specifications approaches for implanting multifocals aim patient selection lifestyle and outlook evaluating biometry patient conversations recommending multifocal iols managing patient expectations staff training implantation postop followup videos and educational materials frequently asked questions acrysof® iq toric iol product information toric iol advantages clinical data specifications connect the dots mastering toric iols patient identification prevalence of astigmatism types of astigmatism toric candidates patient conversations patient identification quiz surgical planning measuring ks topography as a screener accounting for sia using the toric calculator surgical planning quiz toric procedure marking tools marking the eye aligning the iol toric procedure quiz postop assessment resource library acrysof® iq monofocal iol biomaterial excellent capsular bag adhesion low ndyag rates biomechanics precise centration axial stability small incision compatibility biooptics natural light filtration aspheric design night driving photostress recovery  glare disability specifications ultrasert™ preloaded delivery system features  specifications exceptional control smooth injection simple device prep acrysof® iq iol vision simulators treat astigmatism at the time of cataract surgery astigmatism correction with acrysof® iq toric iols crisp clear distance vision for astigmatic cataract patients the proven performance of acrysof® iq toric iols provides cataract treatment and astigmatism correction in a single procedure featuring exceptional rotational stability and a wide range of correction acrysof® iq toric iols can give your patients crisp clear distance vision with reduced dependence on glasses   novartis          usacrea view important product information for acrysof® iq toric iol acrysof® iq toric intraocular lenses important product information caution federal usa law restricts this device to the sale by or on the order of a physician indications the acrysof® iq toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and preexisting corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire improved uncorrected distance vision reduction of residual refractive cylinder and increased spectacle independence for distance vision warningsprecautions careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the riskbenefit ratio before implanting a lens in a patient with any of the conditions described in the directions for use labeling toric iols should not be implanted if the posterior capsule is ruptured if the zonules are damaged or if a primary posterior capsulotomy is planned rotation can reduce astigmatic correction if necessary lens repositioning should occur as early as possible prior to lens encapsulation all viscoelastics should be removed from both the anterior and posterior sides of the lens residual viscoelastics may allow the lens to rotate optical theory suggests that high astigmatic patients ie   d may experience spatial distortions possible toric iol related factors may include residual cylindrical error or axis misalignments prior to surgery physicians should provide prospective patients with a copy of the patient information brochure available from alcon for this product informing them of possible risks and benefits associated with the acrysof® iq toric cylinder power iols studies have shown that color vision discrimination is not adversely affected in individuals with the acrysof® natural iol and normal color vision the effect on vision of the acrysof® natural iol in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease eg glaucoma diabetic retinopathy chronic uveitis and other retinal or optic nerve diseases has not been studied do not resterilize do not store over ° c use only sterile irrigating solutions such as bss® or bss plus® sterile intraocular irrigating solutions attention reference the directions for use labeling for a complete listing of indications warnings and precautions click here to view the acrysof® iq toric iol directions for use dfu acrysof® iq toric intraocular lenses important product information caution federal usa law restricts this device to the sale by or on the order of a physician indications the acrysof® iq toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and preexisting corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire improved uncorrected distance vision reduction of residual refractive cylinder and increased spectacle independence for distance vision warningsprecautions careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the riskbenefit ratio before implanting a lens in a patient with any of the conditions described in the directions for use labeling toric iols should not be implanted if the posterior capsule is ruptured if the zonules are damaged or if a primary posterior capsulotomy is planned rotation can reduce astigmatic correction if necessary lens repositioning should occur as early as possible prior to lens encapsulation all viscoelastics should be removed from both the anterior and posterior sides of the lens residual viscoelastics may allow the lens to rotate optical theory suggests that high astigmatic patients ie   d may experience spatial distortions possible toric iol related factors may include residual cylindrical error or axis misalignments prior to surgery physicians should provide prospective patients with a copy of the patient information brochure available from alcon for this product informing them of possible risks and benefits associated with the acrysof® iq toric cylinder power iols studies have shown that color vision discrimination is not adversely affected in individuals with the acrysof® natural iol and normal color vision the effect on vision of the acrysof® natural iol in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease eg glaucoma diabetic retinopathy chronic uveitis and other retinal or optic nerve diseases has not been studied do not resterilize do not store over ° c use only sterile irrigating solutions such as bss® or bss plus® sterile intraocular irrigating solutions attention reference the directions for use labeling for a complete listing of indications warnings and precautions click here to view the acrysof® iq toric iol directions for use dfu surgical product information  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources label information log in to order use your online ordering id to access your account log in learn more select a product label centurion® vision system centurion® fms pack directions for use centurion® ozil® handpiece directions for use centurion® ultravit® anterior vitrectomy probe pack directions for use constellation® vision system constellation® vision system fragmentation handpiece directions for use cypass® microstent cypass® microstent patient information cypass® microstent product information express® glaucoma filtration device express® glaucoma filtration device infiniti® vision system infiniti® ozil® and us handpiece directions for use intrepid® autosert® iol injector handpiece alcon® intrepid® autosert® iol injector handpiece directions for use iols – delivery systems iol model sncws with acrysert® c monarch® ii a b c monarch® iii c monarch® iii d monarch® iii p acrypak® folder acrysof® iq aspheric iol with the ultrasert® preloaded delivery system – usa only acrysof® iq aspheric iol with the ultrasert® preloaded delivery system iols  acrysof® iq iols model snwf iols  acrysof® multipiece iols model mnac iols  acrysof® multipiece – posterior convex iol  expand® series iols model maac model maac model mabm model mama model mnma iols  acrysof® restor®  iq restor® iols model snad model snad models sndt sndt sndt sndt  directions for use models sndt sndt sndt sndt  patient information brochure model mnad model svt – directions for use model svt – patient instruction booklet models svt svt svt svt  directions for use models svt svt svt svt  patient information brochure iols  acrysof® singlepiece iols model snat model saat model sawf iols  acrysof® toric  iq toric iols model snat snat snat iols  anterior chamber iol model mtauu iols  single piece  monoflex® pmma expand® series iols model mzmd model mzpd iols  single piece pmma iols model mzbd model lxbd model mzbd model mzbd model mcbd model czbd irrigationaspiration ia tips irrigationaspiration ia tips directions for use ophthalmic irrigating solutions and viscosurgical devices product inserts bss plus® sterile intraocular irrigating solution in ml bag bss plus® sterile intraocular irrigating solution in ml glass bottle bss plus® sterile intraocular irrigating solution in ml glass bottle bss® sterile irrigating solution balanced salt solution in ml bag bss® sterile irrigating solution balanced salt solution in ml or ml glass bottle bss® sterile irrigating solution balanced salt solution in ml or  ml droptainer® bottle discovisc® sodium chondroitin sulfate  sodium hyaluronate duovisc® viscoelastic system viscoat® ophthalmic viscosurgical device  provisc® ophthalmic viscosurgical device perfluoron® purified perfluoronoctane liquid provisc® sodium hyaluronate ophthalmic viscosurgical device silikontm  purified polydimethylsiloxane tetracaine hydrochloride ophthalmic solution  steriunits for one time use triesence® triamcinoline acetonaide injectable suspension  mgml viscoat® ophthalmic viscosurgical device sodium chondroitin sulfate  sodium hyaluronate reform® capsular tension rings reform® capsular tension rings small parts kits small parts kits directions for use ultrachopper ultrachopper directions for use ultraflow™ ii ia handpiece ultraflowtm ii ia handpiece directions for use alcon medical information services alcon medical information south freewaymail code tc fort worth texas  united states telephoneus – outside us –  other continents  countries hoursmondayfriday  am –  pmcentral standard time medical information services contact form product material safety data find a material safety data sheet msds for an alcon productsearch now home education  resources label information for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system mri compatible products from alcon  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources mri compatible products log in to order use your online ordering id to access your account log in learn more mri compatible product lookup tool please enter a model number to determine whether the active or inactive alcon product you specify does not contain metallic properties and is considered mri compatible alcon product model number   would you like to check another iol model number quick glance mri compatible products reform capsular tension rings view a printable list of active and inactive alcon products that are mri compatible alcon medical information services alcon medical information south freewaymail code tc fort worth texas  united states telephoneus – outside us –  other continents  countries hoursmondayfriday  am –  pmcentral standard time medical information services contact form related documents view a printable list of active and inactive alcon products that do not contain metallic properties mri compatible products home education  resources mri compatible products for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system alcon surgical suite howto videos  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources alcon surgical suite howto videos log in to order use your online ordering id to access your account log in learn more alcon surgical suite howto videos faq  howto videos designed to reinforce some key aspects from customer training and to provide quick answers for some basic questions our goal is to maximize patient outcomes by increasing the adoption and utilization of new technology through customized peerdriven curriculum and a phased learning approach alcon will further establish itself as the global leader in eye care and as a trusted partner for hcps around the world click on a product to access the video library for that product these videos are approved for use in the united states lensx® laser system view videos veriontm image guided system view videos ora system® view videos wavelight® portfolio view videos home education  resources alcon surgical suite howto videos for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system concert home page  concert pharmaceuticals concert pharmaceuticals at concert we develop new medicines based on two essential drivers innovation and patients we apply our industryleading expertise in deuterium chemistry to create and develop innovative drug products that address important patient needs product pipeline learn about our products in development ➔ deuterium chemistry for patient impact creating novel drugs with the dce platform® ➔ latest news   more ➔ product pipeline  concert pharmaceuticals concert pharmaceuticals product pipeline our innovative approach to drug development has resulted in multiple drug candidates that are progressing in clinical development  for each drug candidate application of our dce platform® resulted in a novel differentiated and potentially superior product building on a product concept that starts with an approved drug through our wholly owned development candidates and our strategic collaborators our dce platformderived pipeline of product candidates includes novel drugs to treat a range of disease areas including autoimmune and inflammatory diseases and central nervous system cns disorders to learn more about concert’s sponsored clinical trials please visit clinicaltrialsgov proprietary drug candidates ctp ctp is an investigational cystic fibrosis transmembrane conductance regulator cftr potentiator that has the potential to be used as part of future oncedaily combination regimens of cftr modulators that treat the underlying cause of cystic fibrosis in a phase  crossover comparison of ctp and kalydeco ctp demonstrated a superior pharmacokinetic profile compared to kalydeco including a reduced rate of clearance longer halflife substantially increased exposure and greater plasma levels at  hours ctp has been granted orphan drug designation by the us food and drug administration fda  in july  vertex acquired  worldwide development and commercialization rights to ctp and other assets related to the treatment of cystic fibrosis ctp ctp is an oral selective inhibitor of certain janus kinases known as jak and jak that we are developing for the treatment of alopecia areata an autoimmune disease that results in partial or complete loss of hair on the scalp andor body ctp was discovered by applying our deuterium chemistry technology to modify ruxolitinib which is commercially available under the name jakafi® in the us for the treatment of myelofibrosis and polycythemia vera ruxolitinib has been used in an academic investigatorsponsored clinical trial and has been shown to promote hair growth in individuals with alopecia areata  we conducted preclinical studies demonstrating that ctp retains ruxolitinib’s jakand jak inhibition profile and showing improved metabolic stability relative to ruxolitinib  a phase a clinical trial evaluating ctp for the treatment of moderatetosevere alopecia areata is underway partnered drug candidates avp avp is a combination of a deuteriumsubstituted dextromethorphan analog and a low dose of quinidine being investigated for the treatment of neurologic and psychiatric disorders avanir is conducting several phase  and phase  clinical trials to evaluate avp for the treatment of neurologic and psychiatric disorders the most advanced of which are phase  clinical trials for the treatment of agitation associated with alzheimer’s disease jzp jzp is a product candidate containing deuterated sodium oxybate for potential use in patients with narcolepsy which is in development in collaboration with jazz pharmaceuticals sodium oxybate is the active ingredient in the marketed drug xyrem jazz pharmaceuticals is exploring formulation options designed to leverage the positive effects observed with jzp in the phase  trials ctp ctp is a deuterated apremilast analog for the potential treatment of inflammatory disease which is in development under a multiproduct collaboration with celgene phase  testing of ctp is complete our dce platformdriven pipeline of product candidates includes novel drugs that offer the potential to target a range of diseases including autoimmune disorders inflammation and cns disorders product pipeline therapeutic applications current openings  concert pharmaceuticals concert pharmaceuticals current openings we invite you to apply for any of our current openings please send your resume in the body text of an email no attachments please to careersconcertpharmacom scientistsenior scientist analytical chemistry scientist clinical pharmacology and development scientistsenior scientist formulation development concert is an equal opportunity employer eoe mfdv working at concert benefits current openings about concert  concert pharmaceuticals concert pharmaceuticals overview at concert pharmaceuticals we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development each of these novel candidates is a result of improving a drug using our deuterium chemistry expanding the potential of an approved drug our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas targeting autoimmune and inflammatory diseases and central nervous system cns disorders our dce platform drives product innovation enabling us to design drug candidates to create differentiated properties and address patient needs  leveraging our team’s deep experience in drug development we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas concert corporate fact sheet concertataglance headquarters lexington ma founded april  nasdaq listed cnce employees  strategic collaborators avanir pharmaceuticals celgene corporation jazz pharmaceuticals proprietary technology dce platform® deuterium chemical entity platform issued us patents  ceo roger tung phd chairman of the board richard aldrich about concert management board of directors strategic collaborations contact management  concert pharmaceuticals concert pharmaceuticals management roger tung phd cofounder president and ceo roger d tung phd is our cofounder and has served as our president and chief executive officer and as a member of our board of directors since april  before concert dr tung was a founding scientist at vertex a pharmaceutical company where he was employed from  to  most recently as its vice president of drug discovery prior to vertex he held various positions at merck sharp  dohme research laboratories a global healthcare provider and the squibb institute for medicinal chemistry  during his career dr tung has overseen the discovery of five drugs approved for the treatment of hiv hepatitis c and cystic fibrosis and was an inventor of several of them  dr tung received a ba in chemistry from reed college and a phd in medicinal chemistry at the university of wisconsinmadison james cassella phd chief development officer dr james cassella has served as our chief development officer since february  prior to joining concert dr cassella served as executive vice president research and development and chief scientific officer of alexza pharmaceuticals inc from june  to january  prior to alexza pharmaceuticals dr cassella held various management positions at neurogen corporation including senior vice president clinical research and development before joining the biotechnology industry dr cassella was assistant professor of neuroscience at oberlin college dr cassella received his phd in physiological psychology from dartmouth college completed a postdoctoral fellowship in the department of psychiatry at the yale university school of medicine and received a ba in psychology from the university of new haven nancy stuart chief operating officer ms nancy stuart has served as our chief operating officer since october  and was our senior vice president corporate strategy and operations from july  to october  prior to joining concert ms stuart held various business operations and business development positions at amgen inc a biopharmaceutical company kinetix pharmaceuticals inc a pharmaceutical company subsequently acquired by amgen vertex a pharmaceutical company and genzyme corporation a biotechnology company subsequently acquired by sanofi sa she also serves on the board of directors of the greater boston ymca ms stuart holds a bs from the university of michigan and an mba from the simmons college graduate school of management lynette herscha general counsel lynette herscha has served as our general counsel and secretary since june  and was our vice president and associate general counsel from july  to june  prior to joining concert she held senior legal positions at momenta pharmaceuticals inc a public biotechnology company and phase forward incorporated a public technology company ms herscha began her career at the law offices of fulbright  jaworksi ms herscha earned her jd from boston university school of law and her ba from boston university concert has built a dynamic management team with broad expertise in drug development and operational excellence biographies of the concert management team are available to download here as a pdf about concert management board of directors strategic collaborations contact contact  concert pharmaceuticals concert pharmaceuticals contact us corporate contacts corporate headquarters concert pharmaceuticals inc  hayden avenue suite  lexington ma   investor and media contact irconcertpharmacom business development contact bdconcertpharmacom general inquiries infoconcertpharmacom about concert management board of directors strategic collaborations contact concert pharmaceuticals inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals concert pharmaceuticals inc  product pipeline review   published oct  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample concert pharmaceuticals inc  product pipeline review   summary global markets direct’s ‘concert pharmaceuticals inc  product pipeline review  ’ provides an overview of the concert pharmaceuticals inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of concert pharmaceuticals inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of concert pharmaceuticals inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of concert pharmaceuticals inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the concert pharmaceuticals inc’s pipeline products reasons to buy  evaluate concert pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of concert pharmaceuticals inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the concert pharmaceuticals inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of concert pharmaceuticals inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of concert pharmaceuticals inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of concert pharmaceuticals inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  concert pharmaceuticals inc snapshot  concert pharmaceuticals inc overview  key information  key facts  concert pharmaceuticals inc  research and development overview  key therapeutic areas  concert pharmaceuticals inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  concert pharmaceuticals inc  pipeline products glance  concert pharmaceuticals inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  concert pharmaceuticals inc  early stage pipeline products  preclinical productscombination treatment modalities  concert pharmaceuticals inc  drug profiles  ctp  product description  mechanism of action  rd progress  c  product description  mechanism of action  rd progress  c  product description  mechanism of action  rd progress  ctp  product description  mechanism of action  rd progress  ctp  product description  mechanism of action  rd progress  ctp  product description  mechanism of action  rd progress  dpraziquantel  product description  mechanism of action  rd progress  concert pharmaceuticals inc  pipeline analysis  concert pharmaceuticals inc  pipeline products by target  concert pharmaceuticals inc  pipeline products by route of administration  concert pharmaceuticals inc  pipeline products by molecule type  concert pharmaceuticals inc  pipeline products by mechanism of action  concert pharmaceuticals inc  recent pipeline updates  concert pharmaceuticals inc  dormant projects  concert pharmaceuticals inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables concert pharmaceuticals inc key information  concert pharmaceuticals inc key facts  concert pharmaceuticals inc  pipeline by indication   concert pharmaceuticals inc  pipeline by stage of development   concert pharmaceuticals inc  monotherapy products in pipeline   concert pharmaceuticals inc  outlicensed products in pipeline   concert pharmaceuticals inc  outlicensed products combination treatment modalities   concert pharmaceuticals inc  phase ii   concert pharmaceuticals inc  phase i   concert pharmaceuticals inc  preclinical   concert pharmaceuticals inc  pipeline by target   concert pharmaceuticals inc  pipeline by route of administration   concert pharmaceuticals inc  pipeline by molecule type   concert pharmaceuticals inc  pipeline products by mechanism of action   concert pharmaceuticals inc  recent pipeline updates   concert pharmaceuticals inc  dormant developmental projects  list of figures concert pharmaceuticals inc  pipeline by top  indication   concert pharmaceuticals inc  pipeline by stage of development   concert pharmaceuticals inc  monotherapy products in pipeline   concert pharmaceuticals inc  outlicensed products in pipeline   concert pharmaceuticals inc  pipeline by top  target   concert pharmaceuticals inc  pipeline by top  route of administration   concert pharmaceuticals inc  pipeline by top  molecule type   concert pharmaceuticals inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports opioidinduced constipation oic  pipeline review h  jul  global markets direct  pages    code  mrs   opioidinduced constipation oic  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide opioidinduced constipation oic  pipeline review h  provides an overview of the opioidinduced constipation oic toxicology pipeline landscape opioids are effective pain relievers but often have the side effect of constipation these medicines affect the gastrointestinal tract in a variety of ways opioids increase the amo read more chemotherapy induced neutropenia  pipeline review h  jul  global markets direct  pages    code  mrs   chemotherapy induced neutropenia  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide chemotherapy induced neutropenia  pipeline review h  provides an overview of the chemotherapy induced neutropenia toxicology pipeline landscape chemotherapyinduced neutropenia is a very common side effect of cancer treatment symptoms include severe fatigue weakness anxiety lack of energy shortness of breath headaches pa read more chemotherapy induced nausea and vomiting  pipeline review h  jul  global markets direct  pages    code  mrs   chemotherapy induced nausea and vomiting  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide chemotherapy induced nausea and vomiting  pipeline review h  provides an overview of the chemotherapy induced nausea and vomiting toxicology pipeline landscape chemotherapy induced nausea and vomiting or cinv is nausea and vomiting that results specifically from treatment with chemotherapy drugs symptoms include a rapi read more px purinoceptor  pz receptor or prx  pipeline review h  jul  global markets direct  pages    code  mrs   px purinoceptor  pz receptor or prx  pipeline review h  summary according to the recently published report px purinoceptor   pipeline review h  px purinoceptor  pz receptor or prx pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies px purinoceptor  pz receptor or prx  px purinoceptor  is a protein encoded by the prx gene it acts as receptor for atp that acts as a ligandgated i read more smoothened homolog protein gx or smo  pipeline review h  jul  global markets direct  pages    code  mrs   smoothened homolog protein gx or smo  pipeline review h  summary smoothened homolog protein gx or smo  smoothened homolog smo is a g proteincoupled receptor that probably associates with the patched protein ptch to transduce the hedgehogs proteins signal binding of sonic hedgehog shh to its receptor is thought to prevent normal inhibition by patched of smoothened smo it is required for the accumulation of kif and gli in the cilia smoothened homolog protein gx read more metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  jul  global markets direct  pages    code  mrs   metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  summary metabotropic glutamate receptor  gprcd or mglur or grm pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining by the universitiesinstitutes the latest report metabotropic glutamate receptor   pipeline review h  outlays comprehensive information on the metabotropic glutamate receptor  gprcd or mglur o read more g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  jul  global markets direct  pages    code  mrs   g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  summary according to the recently published report g protein coupled bile acid receptor   pipeline review h  g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar pipeline target constitutes close to  molecules out of read more alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  jul  global markets direct  pages    code  mrs   alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  summary alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  alphac adrenergic receptor or adrac is an alpha adrenergic receptor it mediates the catecholamineinduced inhibition of adenylate cyclase through the action of g proteins this receptor plays a critical role in regulating neurotransmitt read more tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  jul  global markets direct  pages    code  mrs   tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  summary tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf pipeline targe read more ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  jul  global markets direct  pages    code  mrs   ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  summary according to the recently published report ephrin type b receptor   pipeline review h  ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports product pipeline  concert pharmaceuticals concert pharmaceuticals product pipeline our innovative approach to drug development has resulted in multiple drug candidates that are progressing in clinical development  for each drug candidate application of our dce platform® resulted in a novel differentiated and potentially superior product building on a product concept that starts with an approved drug through our wholly owned development candidates and our strategic collaborators our dce platformderived pipeline of product candidates includes novel drugs to treat a range of disease areas including autoimmune and inflammatory diseases and central nervous system cns disorders to learn more about concert’s sponsored clinical trials please visit clinicaltrialsgov proprietary drug candidates ctp ctp is an investigational cystic fibrosis transmembrane conductance regulator cftr potentiator that has the potential to be used as part of future oncedaily combination regimens of cftr modulators that treat the underlying cause of cystic fibrosis in a phase  crossover comparison of ctp and kalydeco ctp demonstrated a superior pharmacokinetic profile compared to kalydeco including a reduced rate of clearance longer halflife substantially increased exposure and greater plasma levels at  hours ctp has been granted orphan drug designation by the us food and drug administration fda  in july  vertex acquired  worldwide development and commercialization rights to ctp and other assets related to the treatment of cystic fibrosis ctp ctp is an oral selective inhibitor of certain janus kinases known as jak and jak that we are developing for the treatment of alopecia areata an autoimmune disease that results in partial or complete loss of hair on the scalp andor body ctp was discovered by applying our deuterium chemistry technology to modify ruxolitinib which is commercially available under the name jakafi® in the us for the treatment of myelofibrosis and polycythemia vera ruxolitinib has been used in an academic investigatorsponsored clinical trial and has been shown to promote hair growth in individuals with alopecia areata  we conducted preclinical studies demonstrating that ctp retains ruxolitinib’s jakand jak inhibition profile and showing improved metabolic stability relative to ruxolitinib  a phase a clinical trial evaluating ctp for the treatment of moderatetosevere alopecia areata is underway partnered drug candidates avp avp is a combination of a deuteriumsubstituted dextromethorphan analog and a low dose of quinidine being investigated for the treatment of neurologic and psychiatric disorders avanir is conducting several phase  and phase  clinical trials to evaluate avp for the treatment of neurologic and psychiatric disorders the most advanced of which are phase  clinical trials for the treatment of agitation associated with alzheimer’s disease jzp jzp is a product candidate containing deuterated sodium oxybate for potential use in patients with narcolepsy which is in development in collaboration with jazz pharmaceuticals sodium oxybate is the active ingredient in the marketed drug xyrem jazz pharmaceuticals is exploring formulation options designed to leverage the positive effects observed with jzp in the phase  trials ctp ctp is a deuterated apremilast analog for the potential treatment of inflammatory disease which is in development under a multiproduct collaboration with celgene phase  testing of ctp is complete our dce platformdriven pipeline of product candidates includes novel drugs that offer the potential to target a range of diseases including autoimmune disorders inflammation and cns disorders product pipeline therapeutic applications concert pharmaceuticals inc  cnce  stock price today  zacks quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  drugs zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings research report for cnce all zacks’ analyst reports premium research for cnce zacks rank sell  zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores f value  f growth  a momentum  f vgm earnings esp  research report for cnce snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find companies that have recently seen positive earnings estimate revision activity the idea is that more recent information is generally speaking more accurate and can be a better predictor of the future which can give investors an advantage in earnings season the technique has proven to be very useful for finding positive surprises in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time while they also saw  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank concert pharmaceuticals inc cnce alcobra ltd adhd consort medical plc sponsored adr csrmy immune design corp imdz advanced accelerator applications sa aaap aerie pharmaceuticals inc aeri clinigen gp plc cligf see all medical  drugs peers zacks news for cnce vertex vrtx q earnings top on solid cystic fibrosis sales am est zacks heres why investors are glued to vertex pharma vrtx stock am est zacks cnce what are zacks experts saying now zacks private portfolio services concert pharma falls after clinical hold on hair loss drug am est zacks why is vertex pharma vrtx stock soaring this year pm est zacks vertex vrtx q earnings top cf products sales strong am est zacks company summary concert pharmaceuticals inc is a biopharmaceutical company it is focused on applying its dce platform r to create novel small molecule drugs the company manufactures drugs in various therapeutic areas such as hot flashes hiv renal hepatic neuropathic pain mrsa infection and schizophrenia multiple tumors and hyperparathyroidism concert pharmaceuticals inc is based in united states concert pharmaceuticals inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report concert pharmaceuticals inc  product pipeline review   published by global markets direct product code  published october   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license concert pharmaceuticals inc  product pipeline review   published october   content info  pages description summary global markets directs concert pharmaceuticals inc  product pipeline review   provides an overview of the concert pharmaceuticals incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of concert pharmaceuticals incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of concert pharmaceuticals inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of concert pharmaceuticals incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the concert pharmaceuticals incs pipeline products reasons to buy evaluate concert pharmaceuticals incs strategic position with total access to detailed information on its product pipeline assess the growth potential of concert pharmaceuticals inc in its therapy areas of focus identify new drug targets and therapeutic classes in the concert pharmaceuticals incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of concert pharmaceuticals inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of concert pharmaceuticals inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of concert pharmaceuticals inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures concert pharmaceuticals inc snapshot concert pharmaceuticals inc overview key information key facts concert pharmaceuticals inc  research and development overview key therapeutic areas concert pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities concert pharmaceuticals inc  pipeline products glance concert pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities concert pharmaceuticals inc  early stage pipeline products preclinical productscombination treatment modalities concert pharmaceuticals inc  drug profiles ctp product description mechanism of action rd progress c product description mechanism of action rd progress c product description mechanism of action rd progress ctp product description mechanism of action rd progress ctp product description mechanism of action rd progress ctp product description mechanism of action rd progress dpraziquantel product description mechanism of action rd progress concert pharmaceuticals inc  pipeline analysis concert pharmaceuticals inc  pipeline products by target concert pharmaceuticals inc  pipeline products by route of administration concert pharmaceuticals inc  pipeline products by molecule type concert pharmaceuticals inc  pipeline products by mechanism of action concert pharmaceuticals inc  recent pipeline updates concert pharmaceuticals inc  dormant projects concert pharmaceuticals inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables concert pharmaceuticals inc key information concert pharmaceuticals inc key facts concert pharmaceuticals inc  pipeline by indication  concert pharmaceuticals inc  pipeline by stage of development  concert pharmaceuticals inc  monotherapy products in pipeline  concert pharmaceuticals inc  outlicensed products in pipeline  concert pharmaceuticals inc  outlicensed products combination treatment modalities  concert pharmaceuticals inc  phase ii  concert pharmaceuticals inc  phase i  concert pharmaceuticals inc  preclinical  concert pharmaceuticals inc  pipeline by target  concert pharmaceuticals inc  pipeline by route of administration  concert pharmaceuticals inc  pipeline by molecule type  concert pharmaceuticals inc  pipeline products by mechanism of action  concert pharmaceuticals inc  recent pipeline updates  concert pharmaceuticals inc  dormant developmental projects list of figures concert pharmaceuticals inc  pipeline by top  indication  concert pharmaceuticals inc  pipeline by stage of development  concert pharmaceuticals inc  monotherapy products in pipeline  concert pharmaceuticals inc  outlicensed products in pipeline  concert pharmaceuticals inc  pipeline by top  target  concert pharmaceuticals inc  pipeline by top  route of administration  concert pharmaceuticals inc  pipeline by top  molecule type  concert pharmaceuticals inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved concert pharmaceuticals inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports concert pharmaceuticals inc  product pipeline review  concert pharmaceuticals inc  product pipeline review   wgr  october  global  pages global markets direct description table of content sample report enquiry before buy related reports concert pharmaceuticals inc  product pipeline review  summaryglobal markets direct’s ‘concert pharmaceuticals inc  product pipeline review  ’ provides an overview of the concert pharmaceuticals inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of concert pharmaceuticals inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of concert pharmaceuticals inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of concert pharmaceuticals inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the concert pharmaceuticals inc’s pipeline productsreasons to buy evaluate concert pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of concert pharmaceuticals inc in its therapy areas of focus identify new drug targets and therapeutic classes in the concert pharmaceuticals inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of concert pharmaceuticals inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of concert pharmaceuticals inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of concert pharmaceuticals inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures concert pharmaceuticals inc snapshot concert pharmaceuticals inc overview key information key facts concert pharmaceuticals inc  research and development overview key therapeutic areas concert pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities concert pharmaceuticals inc  pipeline products glance concert pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities concert pharmaceuticals inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities concert pharmaceuticals inc  drug profiles ctp product description mechanism of action rd progress ctp product description mechanism of action rd progress c product description mechanism of action rd progress ctp product description mechanism of action rd progress divacaftor product description mechanism of action rd progress dpraziquantel product description mechanism of action rd progress c product description mechanism of action rd progress concert pharmaceuticals inc  pipeline analysis concert pharmaceuticals inc  pipeline products by target concert pharmaceuticals inc  pipeline products by route of administration concert pharmaceuticals inc  pipeline products by molecule type concert pharmaceuticals inc  pipeline products by mechanism of action concert pharmaceuticals inc  recent pipeline updates concert pharmaceuticals inc  dormant projects concert pharmaceuticals inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesconcert pharmaceuticals inc key information concert pharmaceuticals inc key facts concert pharmaceuticals inc  pipeline by indication  concert pharmaceuticals inc  pipeline by stage of development  concert pharmaceuticals inc  monotherapy products in pipeline  concert pharmaceuticals inc  outlicensed products in pipeline  concert pharmaceuticals inc  outlicensed products combination treatment modalities  concert pharmaceuticals inc  phase ii  concert pharmaceuticals inc  phase i  concert pharmaceuticals inc  preclinical  concert pharmaceuticals inc  discovery  concert pharmaceuticals inc  pipeline by target  concert pharmaceuticals inc  pipeline by route of administration  concert pharmaceuticals inc  pipeline by molecule type  concert pharmaceuticals inc  pipeline products by mechanism of action  concert pharmaceuticals inc  recent pipeline updates  concert pharmaceuticals inc  dormant developmental projects list of figuresconcert pharmaceuticals inc  pipeline by top  indication  concert pharmaceuticals inc  pipeline by stage of development  concert pharmaceuticals inc  monotherapy products in pipeline  concert pharmaceuticals inc  outlicensed products in pipeline  concert pharmaceuticals inc  pipeline by top  target  concert pharmaceuticals inc  pipeline by top  route of administration  concert pharmaceuticals inc  pipeline by top  molecule type  concert pharmaceuticals inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send cnce stock price  concert pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin white house gop lawmakers drop borderadjusted tax from reform plan bulletin white house and congressional republicans goal is biggest possible tax cuts bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  ffiv  whr  xl  latest newsall times eastern p breaking white house lawmakers drop border adjustment tax from reform plan p opinion this basic balanced index fund is beating the hedge fund averages p foxconn’s history of broken promises casts a shadow on wisconsin news p semiconductor stocks tumble weighing on the tech sector p white house lawmakers drop border adjusted tax from reform plan p white house lawmakers say goal is to reduce tax rates as much as possible p here’s statement from congress white house on tax reform p gold prices mark a sixweek high p movie chain stocks hurt as results show poor summer slate other woes p breaking nasdaq composite pivots sharply lower in afternoon trade to be replaced home investing quotes stocks united states cnce overview compare quotes stock screener earnings calendar sectors nasdaq cnce us nasdaq join td ameritrade find a broker concert pharmaceuticals inc watchlist createcncealert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones concert pharma stock drops  after fda puts hair loss drug on clinical hold concert pharmaceuticals inc shares dropped  to  wednesday morning after the food and drug administration put its hair loss drug on clinical hold the regulator imposed the hold before subjects in the phase a trial were dosed and said that it needed to review certain toxicology studies to support the oneyear dosing planned for the trial the fda did not cite a safety concern said concert pharma the company plans to submit the requested reports soon after which the fda has  days to tell concert pharma whether it will lift the clinical hold the drug in question ctp is intended for the autoimmune skin disease alopecia areata which causes hair loss typically on the scalp and face and affects nearly  million people in the us according to the national alopecia areata foundation concert pharma shares have risen  over the last three months compared with a  rise in the sp   may   at  am et by emma court concert pharma stock drops  after fda puts hair loss drug on clinical hold concert pharma stock drops  after fda puts hair loss drug on clinical hold may   at  am et by emma court opinion harry boxer’s six biotechnology stocks to watch mar   at  pm et by harry boxer concert pharma shares rally  on news vertex to pay up to  million for cystic fibrosis drug mar   at  am et by ciara linnane concert pharmaceuticals stock resumes trade soars  premarket mar   at  am et by tomi kilgore concert pharamceuticals stock on track to open at month high mar   at  am et by tomi kilgore concert pharamceuticals stock set to resume trade at  am et mar   at  am et by tomi kilgore vertex to buy concert pharmaceuticals cystic fibrosis treatment for  mln and potential milestone payments mar   at  am et by tomi kilgore concert pharmaceuticals stock halted for news mar   at  am et by tomi kilgore concert pharmaceuticals started at buy with  stock price target at stifel nicolaus jul   at  am et by tomi kilgore sector rotation strengthens bear case sep   at  am et by michael ashbaugh energy is less of a drain mar   at  am et on the wall street journal what biotech bubble specialty pharma stocks pop again on merger monday mar   at  pm et on the wall street journal three biotechs ready to partner up sep   at  am et on barrons recent news other news press releases vertex vrtx q earnings top on solid cystic fibrosis sales vertex pharmaceuticals incorporateds vrtx q results were encouraging as it topped earnings and revenues expectations backed by higher sales of both its cf drugs jul   at  am et on zackscom concert pharma shares rally over  level following new buy rating  price target concert pharma shares rally over  level following new buy rating  price target jul   at  am et on benzingacom biotech forum daily digest dynavax technologies moment of truth arrives biotech forum daily digest dynavax technologies moment of truth arrives jul   at  am et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare jul   at  am et on seeking alpha  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha concert pharmaceuticals provides investment opportunity with deuterated drug technology concert pharmaceuticals provides investment opportunity with deuterated drug technology jul   at  am et on seeking alpha heres why investors are glued to vertex pharma vrtx stock vertex pharmaceuticals inc vrtx has been attracting investor attention jun   at  am et on zackscom vertex on the street analysts’ recommendations in june  vertex vrtx has planned to submit a new drug application to the fda in q for a tezacaftorivacaftor combination treatment for cystic fibrosis jun   at  pm et on marketrealistcom great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom concert pharmaceuticals cnce presents at jefferies  global healthcare conference  slideshow concert pharmaceuticals cnce presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha concert pharma falls after clinical hold on hair loss drug concert pharmaceuticals inc cnce shares were down almost  on wednesday after the company announced that the fda has placed a clinical hold on a midstage study evaluating its pipeline candidate ctp for the treatment of alopecia areata may   at  am et on zackscom why is vertex pharma vrtx stock soaring this year vertex pharmaceuticals incs vrtx shares have risen  this year so far outperforming the increase of  for the zacks classified largecap pharma industry may   at  pm et on zackscom  things in biotech you should learn today may    things in biotech you should learn today may   may   at  am et on seeking alpha fda places concert pharmas midstage study of ctp in hair loss disorder on clinical hold pending review of nonclinical toxicology studies shares down  premarket fda places concert pharmas midstage study of ctp in hair loss disorder on clinical hold pending review of nonclinical toxicology studies shares down  premarket may   at  am et on seeking alpha concert pharmaceuticals cnce ceo roger tung on q  results  earnings call transcript concert pharmaceuticals cnce ceo roger tung on q  results  earnings call transcript may   at  pm et on seeking alpha q concert pharmaceuticals inc q concert pharmaceuticals inc may   at  am et on edgar online  edg  q k evaluating the strength of concert pharmaceuticals broad patent estate covering deuterated compounds evaluating the strength of concert pharmaceuticals broad patent estate covering deuterated compounds may   at  pm et on seeking alpha vertex pharmaceuticals incorporated solid sales prepping for next generation may   at  pm et on motley fool vertex vrtx q earnings top cf products sales strong apr   at  am et on zackscom concert pharmaceuticals still upside ahead after major rally apr   at  am et on seeking alpha vertex and concert pharmaceuticals complete asset purchase agreement for ctp vertex and concert pharmaceuticals complete asset purchase agreement for ctp jul   at  pm et on businesswire  bzx concert pharmaceuticals announces termination of the hsr act waiting period for ctp asset purchase agreement with vertex concert pharmaceuticals announces termination of the hsr act waiting period for ctp asset purchase agreement with vertex jul   at  am et on businesswire  bzx global sedatives market research report  industry analysis size share growth trends and forecast global sedatives market research report  industry analysis size share growth trends and forecast jul   at  pm et on pr newswire  prf fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp jul   at  am et on businesswire  bzx concert pharmaceuticals announces  million venture debt financing from hercules capital concert pharmaceuticals announces  million venture debt financing from hercules capital jun   at  am et on businesswire  bzx research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma jun   at  am et on pr newswire  prf concert pharmaceuticals announces departure of chief financial officer ryan daws concert pharmaceuticals announces departure of chief financial officer ryan daws may   at  am et on businesswire  bzx concert pharmaceuticals to present at upcoming investor conferences concert pharmaceuticals to present at upcoming investor conferences may   at  am et on businesswire  bzx concert pharmaceuticals announces shareholder approval of ctp asset purchase agreement with vertex pharmaceuticals concert pharmaceuticals announces shareholder approval of ctp asset purchase agreement with vertex pharmaceuticals may   at  am et on businesswire  bzx concert pharmaceuticals receives second request from ftc under hsr act concert pharmaceuticals receives second request from ftc under hsr act may   at  am et on businesswire  bzx concert pharmaceuticals announces clinical hold on ctp phase a trial concert pharmaceuticals announces clinical hold on ctp phase a trial may   at  am et on businesswire  bzx investor network concert pharmaceuticals inc to host earnings call investor network concert pharmaceuticals inc to host earnings call may   at  am et on accesswire concert pharmaceuticals reports first quarter  financial results concert pharmaceuticals reports first quarter  financial results may   at  am et on businesswire  bzx concert pharmaceuticals initiates ctp phase  trial in alopecia areata concert pharmaceuticals initiates ctp phase  trial in alopecia areata may   at  am et on businesswire  bzx concert pharmaceuticals to report first quarter  financial results on may   and present at upcoming investor conferences apr   at  am et on businesswire  bzx rdinvestingcom coverage initiated on concert pharmaceuticals price surges mar   at  am et on accesswire vertex to acquire ctp from concert pharmaceuticals for the treatment of cystic fibrosis mar   at  am et on businesswire  bzx vertex to acquire ctp from concert pharmaceuticals for the treatment of cystic fibrosis mar   at  am et on businesswire  bzx concert pharmaceuticals presents ctp phase  results at american academy of dermatology annual meeting mar   at  am et on businesswire  bzx concert pharmaceuticals to report full year  results on march   and present at upcoming investor conferences mar   at  am et on businesswire  bzx concert pharmaceuticals inc concert pharmaceuticals inc is a clinical stage biopharmaceutical company which discovers and develops novel small molecule drugs for renal disease cns disorders inflammation and hematologic disorders it also creates novel medicines that address commercially important needs by applying its deuterated chemical entity platform to compounds with wellcharacterized pharmacological activity the company was founded by richard h aldrich roger d tung and christoph h westphal on april   and is headquartered in lexington ma see full profile analyst ratings sell under hold over buy number of ratings  full ratings concert pharma shares rally over  level following new buy rating  price target jul   at  am et on benzingacom benzingas top upgrades downgrades for july   jul   at  am et on benzingacom benzingas top initiations aug   at  am et on benzingacom competitors name chg  market cap celgene corp  b jazz pharmaceuticals plc  b abbvie inc  b gw pharmaceuticals plc adr  b trevena inc  m competitor data provided by partner content trending tickers powered by amzn  fb  aapl  amd  shop  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index x tweet share this bulletin get news bulletins by email bulletin white house gop lawmakers drop borderadjusted tax from reform plan » investor alert new york markets close in market snapshot winners and losers x tweet share this bulletin get news bulletins by email bulletin white house and congressional republicans goal is biggest possible tax cuts » stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pbreakingwhite house lawmakers drop border adjustment tax from reform plan pthis basic balanced index fund is beating the hedge fund averages pfoxconn’s history of broken promises casts a shadow on wisconsin news pwhite house lawmakers drop border adjusted tax from reform plan psemiconductor stocks tumble weighing on the tech sector pwhite house lawmakers say goal is to reduce tax rates as much as possible phere’s statement from congress white house on tax reform pgold prices mark a sixweek high pmovie chain stocks hurt as results show poor summer slate other woes pbreakingnasdaq composite pivots sharply lower in afternoon trade pexobama official pours cold water on trump’s corporate tax cut target ptrump’s antidemocratic presidency helps republicans stay in power paugust gold climbs by  or  to settle at oz pgold prices log highest finish since the middle of june pishares phlx semiconductor etf down  pbuffalo wild wings shares down  in thursday trading pbuffalo wild wings price target cut to  from  at canaccord genuity pstock market retreats from records as tech stocks drop sharply pwhy the gdp report may show us economy growing twice as fast pwhy it was easy for investigators to find the dean foods insider trades that got billy walters jailed loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index x tweet share this bulletin get news bulletins by email bulletin white house gop lawmakers drop borderadjusted tax from reform plan » investor alert new york markets close in market snapshot winners and losers x tweet share this bulletin get news bulletins by email bulletin white house and congressional republicans goal is biggest possible tax cuts » stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pbreakingwhite house lawmakers drop border adjustment tax from reform plan pthis basic balanced index fund is beating the hedge fund averages pfoxconn’s history of broken promises casts a shadow on wisconsin news pwhite house lawmakers drop border adjusted tax from reform plan psemiconductor stocks tumble weighing on the tech sector pwhite house lawmakers say goal is to reduce tax rates as much as possible phere’s statement from congress white house on tax reform pgold prices mark a sixweek high pmovie chain stocks hurt as results show poor summer slate other woes pbreakingnasdaq composite pivots sharply lower in afternoon trade pexobama official pours cold water on trump’s corporate tax cut target ptrump’s antidemocratic presidency helps republicans stay in power paugust gold climbs by  or  to settle at oz pgold prices log highest finish since the middle of june pishares phlx semiconductor etf down  pbuffalo wild wings shares down  in thursday trading pbuffalo wild wings price target cut to  from  at canaccord genuity pstock market retreats from records as tech stocks drop sharply pwhy the gdp report may show us economy growing twice as fast pwhy it was easy for investigators to find the dean foods insider trades that got billy walters jailed loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index x tweet share this bulletin get news bulletins by email bulletin white house gop lawmakers drop borderadjusted tax from reform plan » investor alert new york markets close in market snapshot winners and losers x tweet share this bulletin get news bulletins by email bulletin white house and congressional republicans goal is biggest possible tax cuts » stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pbreakingwhite house lawmakers drop border adjustment tax from reform plan pthis basic balanced index fund is beating the hedge fund averages pfoxconn’s history of broken promises casts a shadow on wisconsin news pwhite house lawmakers drop border adjusted tax from reform plan psemiconductor stocks tumble weighing on the tech sector pwhite house lawmakers say goal is to reduce tax rates as much as possible phere’s statement from congress white house on tax reform pgold prices mark a sixweek high pmovie chain stocks hurt as results show poor summer slate other woes pbreakingnasdaq composite pivots sharply lower in afternoon trade pexobama official pours cold water on trump’s corporate tax cut target ptrump’s antidemocratic presidency helps republicans stay in power paugust gold climbs by  or  to settle at oz pgold prices log highest finish since the middle of june pishares phlx semiconductor etf down  pbuffalo wild wings shares down  in thursday trading pbuffalo wild wings price target cut to  from  at canaccord genuity pstock market retreats from records as tech stocks drop sharply pwhy the gdp report may show us economy growing twice as fast pwhy it was easy for investigators to find the dean foods insider trades that got billy walters jailed loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cnce stock price  concert pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin white house gop lawmakers drop borderadjusted tax from reform plan bulletin white house and congressional republicans goal is biggest possible tax cuts bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  ffiv  whr  xl  latest newsall times eastern p breaking white house lawmakers drop border adjustment tax from reform plan p opinion this basic balanced index fund is beating the hedge fund averages p foxconn’s history of broken promises casts a shadow on wisconsin news p semiconductor stocks tumble weighing on the tech sector p white house lawmakers drop border adjusted tax from reform plan p white house lawmakers say goal is to reduce tax rates as much as possible p here’s statement from congress white house on tax reform p gold prices mark a sixweek high p movie chain stocks hurt as results show poor summer slate other woes p breaking nasdaq composite pivots sharply lower in afternoon trade to be replaced home investing quotes stocks united states cnce overview compare quotes stock screener earnings calendar sectors nasdaq cnce us nasdaq join td ameritrade find a broker concert pharmaceuticals inc watchlist createcncealert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones concert pharma stock drops  after fda puts hair loss drug on clinical hold concert pharmaceuticals inc shares dropped  to  wednesday morning after the food and drug administration put its hair loss drug on clinical hold the regulator imposed the hold before subjects in the phase a trial were dosed and said that it needed to review certain toxicology studies to support the oneyear dosing planned for the trial the fda did not cite a safety concern said concert pharma the company plans to submit the requested reports soon after which the fda has  days to tell concert pharma whether it will lift the clinical hold the drug in question ctp is intended for the autoimmune skin disease alopecia areata which causes hair loss typically on the scalp and face and affects nearly  million people in the us according to the national alopecia areata foundation concert pharma shares have risen  over the last three months compared with a  rise in the sp   may   at  am et by emma court concert pharma stock drops  after fda puts hair loss drug on clinical hold concert pharma stock drops  after fda puts hair loss drug on clinical hold may   at  am et by emma court opinion harry boxer’s six biotechnology stocks to watch mar   at  pm et by harry boxer concert pharma shares rally  on news vertex to pay up to  million for cystic fibrosis drug mar   at  am et by ciara linnane concert pharmaceuticals stock resumes trade soars  premarket mar   at  am et by tomi kilgore concert pharamceuticals stock on track to open at month high mar   at  am et by tomi kilgore concert pharamceuticals stock set to resume trade at  am et mar   at  am et by tomi kilgore vertex to buy concert pharmaceuticals cystic fibrosis treatment for  mln and potential milestone payments mar   at  am et by tomi kilgore concert pharmaceuticals stock halted for news mar   at  am et by tomi kilgore concert pharmaceuticals started at buy with  stock price target at stifel nicolaus jul   at  am et by tomi kilgore sector rotation strengthens bear case sep   at  am et by michael ashbaugh energy is less of a drain mar   at  am et on the wall street journal what biotech bubble specialty pharma stocks pop again on merger monday mar   at  pm et on the wall street journal three biotechs ready to partner up sep   at  am et on barrons recent news other news press releases vertex vrtx q earnings top on solid cystic fibrosis sales vertex pharmaceuticals incorporateds vrtx q results were encouraging as it topped earnings and revenues expectations backed by higher sales of both its cf drugs jul   at  am et on zackscom concert pharma shares rally over  level following new buy rating  price target concert pharma shares rally over  level following new buy rating  price target jul   at  am et on benzingacom biotech forum daily digest dynavax technologies moment of truth arrives biotech forum daily digest dynavax technologies moment of truth arrives jul   at  am et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare jul   at  am et on seeking alpha  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha concert pharmaceuticals provides investment opportunity with deuterated drug technology concert pharmaceuticals provides investment opportunity with deuterated drug technology jul   at  am et on seeking alpha heres why investors are glued to vertex pharma vrtx stock vertex pharmaceuticals inc vrtx has been attracting investor attention jun   at  am et on zackscom vertex on the street analysts’ recommendations in june  vertex vrtx has planned to submit a new drug application to the fda in q for a tezacaftorivacaftor combination treatment for cystic fibrosis jun   at  pm et on marketrealistcom great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom concert pharmaceuticals cnce presents at jefferies  global healthcare conference  slideshow concert pharmaceuticals cnce presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha concert pharma falls after clinical hold on hair loss drug concert pharmaceuticals inc cnce shares were down almost  on wednesday after the company announced that the fda has placed a clinical hold on a midstage study evaluating its pipeline candidate ctp for the treatment of alopecia areata may   at  am et on zackscom why is vertex pharma vrtx stock soaring this year vertex pharmaceuticals incs vrtx shares have risen  this year so far outperforming the increase of  for the zacks classified largecap pharma industry may   at  pm et on zackscom  things in biotech you should learn today may    things in biotech you should learn today may   may   at  am et on seeking alpha fda places concert pharmas midstage study of ctp in hair loss disorder on clinical hold pending review of nonclinical toxicology studies shares down  premarket fda places concert pharmas midstage study of ctp in hair loss disorder on clinical hold pending review of nonclinical toxicology studies shares down  premarket may   at  am et on seeking alpha concert pharmaceuticals cnce ceo roger tung on q  results  earnings call transcript concert pharmaceuticals cnce ceo roger tung on q  results  earnings call transcript may   at  pm et on seeking alpha q concert pharmaceuticals inc q concert pharmaceuticals inc may   at  am et on edgar online  edg  q k evaluating the strength of concert pharmaceuticals broad patent estate covering deuterated compounds evaluating the strength of concert pharmaceuticals broad patent estate covering deuterated compounds may   at  pm et on seeking alpha vertex pharmaceuticals incorporated solid sales prepping for next generation may   at  pm et on motley fool vertex vrtx q earnings top cf products sales strong apr   at  am et on zackscom concert pharmaceuticals still upside ahead after major rally apr   at  am et on seeking alpha vertex and concert pharmaceuticals complete asset purchase agreement for ctp vertex and concert pharmaceuticals complete asset purchase agreement for ctp jul   at  pm et on businesswire  bzx concert pharmaceuticals announces termination of the hsr act waiting period for ctp asset purchase agreement with vertex concert pharmaceuticals announces termination of the hsr act waiting period for ctp asset purchase agreement with vertex jul   at  am et on businesswire  bzx global sedatives market research report  industry analysis size share growth trends and forecast global sedatives market research report  industry analysis size share growth trends and forecast jul   at  pm et on pr newswire  prf fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp jul   at  am et on businesswire  bzx concert pharmaceuticals announces  million venture debt financing from hercules capital concert pharmaceuticals announces  million venture debt financing from hercules capital jun   at  am et on businesswire  bzx research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma jun   at  am et on pr newswire  prf concert pharmaceuticals announces departure of chief financial officer ryan daws concert pharmaceuticals announces departure of chief financial officer ryan daws may   at  am et on businesswire  bzx concert pharmaceuticals to present at upcoming investor conferences concert pharmaceuticals to present at upcoming investor conferences may   at  am et on businesswire  bzx concert pharmaceuticals announces shareholder approval of ctp asset purchase agreement with vertex pharmaceuticals concert pharmaceuticals announces shareholder approval of ctp asset purchase agreement with vertex pharmaceuticals may   at  am et on businesswire  bzx concert pharmaceuticals receives second request from ftc under hsr act concert pharmaceuticals receives second request from ftc under hsr act may   at  am et on businesswire  bzx concert pharmaceuticals announces clinical hold on ctp phase a trial concert pharmaceuticals announces clinical hold on ctp phase a trial may   at  am et on businesswire  bzx investor network concert pharmaceuticals inc to host earnings call investor network concert pharmaceuticals inc to host earnings call may   at  am et on accesswire concert pharmaceuticals reports first quarter  financial results concert pharmaceuticals reports first quarter  financial results may   at  am et on businesswire  bzx concert pharmaceuticals initiates ctp phase  trial in alopecia areata concert pharmaceuticals initiates ctp phase  trial in alopecia areata may   at  am et on businesswire  bzx concert pharmaceuticals to report first quarter  financial results on may   and present at upcoming investor conferences apr   at  am et on businesswire  bzx rdinvestingcom coverage initiated on concert pharmaceuticals price surges mar   at  am et on accesswire vertex to acquire ctp from concert pharmaceuticals for the treatment of cystic fibrosis mar   at  am et on businesswire  bzx vertex to acquire ctp from concert pharmaceuticals for the treatment of cystic fibrosis mar   at  am et on businesswire  bzx concert pharmaceuticals presents ctp phase  results at american academy of dermatology annual meeting mar   at  am et on businesswire  bzx concert pharmaceuticals to report full year  results on march   and present at upcoming investor conferences mar   at  am et on businesswire  bzx concert pharmaceuticals inc concert pharmaceuticals inc is a clinical stage biopharmaceutical company which discovers and develops novel small molecule drugs for renal disease cns disorders inflammation and hematologic disorders it also creates novel medicines that address commercially important needs by applying its deuterated chemical entity platform to compounds with wellcharacterized pharmacological activity the company was founded by richard h aldrich roger d tung and christoph h westphal on april   and is headquartered in lexington ma see full profile analyst ratings sell under hold over buy number of ratings  full ratings concert pharma shares rally over  level following new buy rating  price target jul   at  am et on benzingacom benzingas top upgrades downgrades for july   jul   at  am et on benzingacom benzingas top initiations aug   at  am et on benzingacom competitors name chg  market cap celgene corp  b jazz pharmaceuticals plc  b abbvie inc  b gw pharmaceuticals plc adr  b trevena inc  m competitor data provided by partner content trending tickers powered by amzn  fb  aapl  amd  shop  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience concert pharmaceuticals inc private company information  bloomberg july    pm et biotechnology company overview of concert pharmaceuticals inc snapshot people company overview concert pharmaceuticals inc operates as a clinical stage biopharmaceutical company it discovers and develops novel small molecule drugs for use in the treatment of various pulmonary diseases including cystic fibrosis autoimmune and inflammatory diseases and central nervous systems disorders the company’s clinicalstage product candidates include avp which is in phase  clinical trials for the treatment of neurologic and psychiatric disorders including agitation associated with alzheimer’s disease and ctp which is in phase  clinical trials to treat cystic fibrosis it product candidates that have completed phase  clinical trials comprise ctp for use in the treatment o concert pharmaceuticals inc operates as a clinical stage biopharmaceutical company it discovers and develops novel small molecule drugs for use in the treatment of various pulmonary diseases including cystic fibrosis autoimmune and inflammatory diseases and central nervous systems disorders the company’s clinicalstage product candidates include avp which is in phase  clinical trials for the treatment of neurologic and psychiatric disorders including agitation associated with alzheimer’s disease and ctp which is in phase  clinical trials to treat cystic fibrosis it product candidates that have completed phase  clinical trials comprise ctp for use in the treatment of inflammation or cancer jzp for use in the treatment of excessive daytime sleepiness and cataplexy and ctp for use in the treatment of alopecia areata the company has strategic collaborations with celgene pharmaceuticals inc celgene international sarl celgene corporation avanir pharmaceuticals inc and jazz pharmaceuticals inc concert pharmaceuticals inc was founded in  and is headquartered in lexington massachusetts detailed description  hayden avenuesuite lexington ma united statesfounded in  employees phone  wwwconcertpharmacom key executives for concert pharmaceuticals inc dr roger d tung phd cofounder ceo president  director age  total annual compensation k ms nancy stuart chief operating officer age  total annual compensation k dr james v cassella phd chief development officer and senior vice president age  total annual compensation k dr ian robert silverman jd phd senior legal advisor age  total annual compensation k compensation as of fiscal year  concert pharmaceuticals inc key developments concert pharmaceuticals inc appoints ryan lynch as the principal financial officer and principal accounting officer jun   concert pharmaceuticals inc announced that ryan lynch was appointed by the board of directors of the corporation as the principal financial officer and principal accounting officer concert pharmaceuticals inc enters into loan and security agreement with hercules capital inc jun   on june   the closing date concert pharmaceuticals inc the company entered into a loan and security agreement the loan agreement with hercules capital inc hercules pursuant to which hercules agreed to make available to the company a secured term loan facility in the amount of  million the term loan facility subject to certain terms and conditions the company borrowed  million under the loan agreement in one advance advances under the term loan facility bear interest at a rate per annum equal to the greater of either  plus the prime rate as reported in the wall street journal minus  and  the loan agreement includes covenants limitations and events of default customary for similar facilities the term of the loan agreement is four years ending june   the maturity date interest is payable on a monthly basis until january   the amortization date after the amortization date payments shall consist of equal monthly installments of principal and interest payable over the next  months the company will pay a charge of  on the date that the term loan facility is paid in full or becomes due and payable the end of term charge will be reduced to  if the company completes the vertex transaction and prepays the term loan facility after the th day following the closing date but prior to the six month anniversary of the closing date the term loan facility is secured by substantially all of the company’s assets including all securities in domestic subsidiaries and  of the securities in foreign subsidiaries but excluding its intellectual property and subject to certain exceptions and exclusions concert pharmaceuticals announces departure of chief financial officer ryan daws may   concert pharmaceuticals inc announced that ryan daws chief financial officer will be leaving the company in early june  to return to investment banking he will be joining baird as managing director in the firms life sciences and biotechnology group mr daws will continue to consult with the company including through the closing of the pending asset purchase agreement with vertex pharmaceuticals inc mr daws served as cfo of company since january  similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement june    mergeracquisition march   concert pharmaceuticals inc ct drug  related assets request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact concert pharmaceuticals inc please visit wwwconcertpharmacom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close cncenasdaq gm stock quote  concert pharmaceuticals inc  bloomberg markets error could not add to watchlist x  watchlist concert pharmaceuticals inc cnceus nasdaq gm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  vertex and concert pharmaceuticals complete asset purchase agreement for ctp  concert pharmaceuticals announces termination of the hsr act waiting period for ctp asset purchase agreement with vertex  fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp  cystic fibrosis therapeutics pipeline h  research report available at rnr market research  concert pharmaceuticals announces  million venture debt financing from hercules capital  concert pharmaceuticals to present at upcoming investor conferences  concert pharmaceuticals announces departure of chief financial officer ryan daws  concert pharmaceuticals announces shareholder approval of ctp asset purchase agreement with vertex pharmaceuticals  concert pharmaceuticals receives second request from ftc under hsr act  concert pharmaceuticals announces clinical hold on ctp phase a trial there are currently no press releases for this ticker please check back later profile concert pharmaceuticals inc is a clinical stage biotechnology company the company focuses on the use of deuterium to enhance the effects of approved drugs concert pharmaceuticals offers its products throughout the united states address  hayden avenuesuite lexington ma united states phone  website wwwconcertpharmacom executives board members roger d tung presidentceocofounder nancy stuart chief operating officer lynette herscha senior vpsecygeneral counsel james v cassella jim chief development officer ryan lynch principal acctg ofcrcontroller show more contact us  concert pharmaceuticals concert pharmaceuticals contact us ir contact justine e koenigsberg vice presidentcorporate communicationsand investor relations  irconcertpharmacom please submit your question using the form below  indicates required field name email subject comments listen to audio version type in number submit comment nasdaq cnce     day high  day low   volume      pm et on jul   delayed  min by esignal intra  mo  mo  yr overview press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual meeting stock information historic stock lookup investment calculator analyst coverage investor faqs contact us briefcase briefcase printed materials printed materials email alerts email alerts downloads downloads snapshot snapshot rss rss print print email email share share search search facebook google linkedin twitter email rss microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ﻿ acrysof® iq toric iols  myalconcom  back to resources for eye care and health care professionals contact us print cataract equipment centurion® vision system infiniti® vision system lensx® laser system luxor™ ophthalmic microscope cataract refractive diagnostics cataract iols acrysof® iq restor® multifocal iols acrysof® iq toric iol acrysof® iq monofocal iol ultrasert™ preloaded delivery system acrysof® iq iol vision simulator cataract disposables bss plus® irrigating solution ophthalmic viscosurgical devices ovds refractive technology surgical diagnostics devices wavelight® refractive suite wavelight® allegretto wave® eyeq laser videos and resources wavelight® tcat study surgical glaucoma express® glaucoma filtration device vitreoretinal surgery vitreoretinal surgical constellation® vision system alcon® mivs portfolio grieshaber® dsp instrumentation purepoint® laser retinal stabilizing adjuncts tools  resources iol calculations label information us technical service reimbursement services “find an eye surgeon” profile mri compatible products natural rubber latex product list alcon medical education grants medical missions cataract iols acrysof® iq restor® multifocal iols overview and key features design comparison visual performance patient profile specifications acrysof® iq restor®  d iol diffractive optic design data support specifications acrysof® iq restor®  d iol diffractive optic design data support specifications approaches for implanting multifocals aim patient selection lifestyle and outlook evaluating biometry patient conversations recommending multifocal iols managing patient expectations staff training implantation postop followup videos and educational materials frequently asked questions acrysof® iq toric iol product information toric iol advantages clinical data specifications connect the dots mastering toric iols patient identification prevalence of astigmatism types of astigmatism toric candidates patient conversations patient identification quiz surgical planning measuring ks topography as a screener accounting for sia using the toric calculator surgical planning quiz toric procedure marking tools marking the eye aligning the iol toric procedure quiz postop assessment resource library acrysof® iq monofocal iol biomaterial excellent capsular bag adhesion low ndyag rates biomechanics precise centration axial stability small incision compatibility biooptics natural light filtration aspheric design night driving photostress recovery  glare disability specifications ultrasert™ preloaded delivery system features  specifications exceptional control smooth injection simple device prep acrysof® iq iol vision simulators treat astigmatism at the time of cataract surgery astigmatism correction with acrysof® iq toric iols crisp clear distance vision for astigmatic cataract patients the proven performance of acrysof® iq toric iols provides cataract treatment and astigmatism correction in a single procedure featuring exceptional rotational stability and a wide range of correction acrysof® iq toric iols can give your patients crisp clear distance vision with reduced dependence on glasses   novartis          usacrea view important product information for acrysof® iq toric iol acrysof® iq toric intraocular lenses important product information caution federal usa law restricts this device to the sale by or on the order of a physician indications the acrysof® iq toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and preexisting corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire improved uncorrected distance vision reduction of residual refractive cylinder and increased spectacle independence for distance vision warningsprecautions careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the riskbenefit ratio before implanting a lens in a patient with any of the conditions described in the directions for use labeling toric iols should not be implanted if the posterior capsule is ruptured if the zonules are damaged or if a primary posterior capsulotomy is planned rotation can reduce astigmatic correction if necessary lens repositioning should occur as early as possible prior to lens encapsulation all viscoelastics should be removed from both the anterior and posterior sides of the lens residual viscoelastics may allow the lens to rotate optical theory suggests that high astigmatic patients ie   d may experience spatial distortions possible toric iol related factors may include residual cylindrical error or axis misalignments prior to surgery physicians should provide prospective patients with a copy of the patient information brochure available from alcon for this product informing them of possible risks and benefits associated with the acrysof® iq toric cylinder power iols studies have shown that color vision discrimination is not adversely affected in individuals with the acrysof® natural iol and normal color vision the effect on vision of the acrysof® natural iol in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease eg glaucoma diabetic retinopathy chronic uveitis and other retinal or optic nerve diseases has not been studied do not resterilize do not store over ° c use only sterile irrigating solutions such as bss® or bss plus® sterile intraocular irrigating solutions attention reference the directions for use labeling for a complete listing of indications warnings and precautions click here to view the acrysof® iq toric iol directions for use dfu acrysof® iq toric intraocular lenses important product information caution federal usa law restricts this device to the sale by or on the order of a physician indications the acrysof® iq toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and preexisting corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire improved uncorrected distance vision reduction of residual refractive cylinder and increased spectacle independence for distance vision warningsprecautions careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the riskbenefit ratio before implanting a lens in a patient with any of the conditions described in the directions for use labeling toric iols should not be implanted if the posterior capsule is ruptured if the zonules are damaged or if a primary posterior capsulotomy is planned rotation can reduce astigmatic correction if necessary lens repositioning should occur as early as possible prior to lens encapsulation all viscoelastics should be removed from both the anterior and posterior sides of the lens residual viscoelastics may allow the lens to rotate optical theory suggests that high astigmatic patients ie   d may experience spatial distortions possible toric iol related factors may include residual cylindrical error or axis misalignments prior to surgery physicians should provide prospective patients with a copy of the patient information brochure available from alcon for this product informing them of possible risks and benefits associated with the acrysof® iq toric cylinder power iols studies have shown that color vision discrimination is not adversely affected in individuals with the acrysof® natural iol and normal color vision the effect on vision of the acrysof® natural iol in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease eg glaucoma diabetic retinopathy chronic uveitis and other retinal or optic nerve diseases has not been studied do not resterilize do not store over ° c use only sterile irrigating solutions such as bss® or bss plus® sterile intraocular irrigating solutions attention reference the directions for use labeling for a complete listing of indications warnings and precautions click here to view the acrysof® iq toric iol directions for use dfu surgical product information  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources label information log in to order use your online ordering id to access your account log in learn more select a product label centurion® vision system centurion® fms pack directions for use centurion® ozil® handpiece directions for use centurion® ultravit® anterior vitrectomy probe pack directions for use constellation® vision system constellation® vision system fragmentation handpiece directions for use cypass® microstent cypass® microstent patient information cypass® microstent product information express® glaucoma filtration device express® glaucoma filtration device infiniti® vision system infiniti® ozil® and us handpiece directions for use intrepid® autosert® iol injector handpiece alcon® intrepid® autosert® iol injector handpiece directions for use iols – delivery systems iol model sncws with acrysert® c monarch® ii a b c monarch® iii c monarch® iii d monarch® iii p acrypak® folder acrysof® iq aspheric iol with the ultrasert® preloaded delivery system – usa only acrysof® iq aspheric iol with the ultrasert® preloaded delivery system iols  acrysof® iq iols model snwf iols  acrysof® multipiece iols model mnac iols  acrysof® multipiece – posterior convex iol  expand® series iols model maac model maac model mabm model mama model mnma iols  acrysof® restor®  iq restor® iols model snad model snad models sndt sndt sndt sndt  directions for use models sndt sndt sndt sndt  patient information brochure model mnad model svt – directions for use model svt – patient instruction booklet models svt svt svt svt  directions for use models svt svt svt svt  patient information brochure iols  acrysof® singlepiece iols model snat model saat model sawf iols  acrysof® toric  iq toric iols model snat snat snat iols  anterior chamber iol model mtauu iols  single piece  monoflex® pmma expand® series iols model mzmd model mzpd iols  single piece pmma iols model mzbd model lxbd model mzbd model mzbd model mcbd model czbd irrigationaspiration ia tips irrigationaspiration ia tips directions for use ophthalmic irrigating solutions and viscosurgical devices product inserts bss plus® sterile intraocular irrigating solution in ml bag bss plus® sterile intraocular irrigating solution in ml glass bottle bss plus® sterile intraocular irrigating solution in ml glass bottle bss® sterile irrigating solution balanced salt solution in ml bag bss® sterile irrigating solution balanced salt solution in ml or ml glass bottle bss® sterile irrigating solution balanced salt solution in ml or  ml droptainer® bottle discovisc® sodium chondroitin sulfate  sodium hyaluronate duovisc® viscoelastic system viscoat® ophthalmic viscosurgical device  provisc® ophthalmic viscosurgical device perfluoron® purified perfluoronoctane liquid provisc® sodium hyaluronate ophthalmic viscosurgical device silikontm  purified polydimethylsiloxane tetracaine hydrochloride ophthalmic solution  steriunits for one time use triesence® triamcinoline acetonaide injectable suspension  mgml viscoat® ophthalmic viscosurgical device sodium chondroitin sulfate  sodium hyaluronate reform® capsular tension rings reform® capsular tension rings small parts kits small parts kits directions for use ultrachopper ultrachopper directions for use ultraflow™ ii ia handpiece ultraflowtm ii ia handpiece directions for use alcon medical information services alcon medical information south freewaymail code tc fort worth texas  united states telephoneus – outside us –  other continents  countries hoursmondayfriday  am –  pmcentral standard time medical information services contact form product material safety data find a material safety data sheet msds for an alcon productsearch now home education  resources label information for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system mri compatible products from alcon  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources mri compatible products log in to order use your online ordering id to access your account log in learn more mri compatible product lookup tool please enter a model number to determine whether the active or inactive alcon product you specify does not contain metallic properties and is considered mri compatible alcon product model number   would you like to check another iol model number quick glance mri compatible products reform capsular tension rings view a printable list of active and inactive alcon products that are mri compatible alcon medical information services alcon medical information south freewaymail code tc fort worth texas  united states telephoneus – outside us –  other continents  countries hoursmondayfriday  am –  pmcentral standard time medical information services contact form related documents view a printable list of active and inactive alcon products that do not contain metallic properties mri compatible products home education  resources mri compatible products for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system alcon surgical suite howto videos  myalconcom additionally paste this code immediately after the opening tag × resources for eye care professionals home education  resources alcon surgical suite howto videos log in to order use your online ordering id to access your account log in learn more alcon surgical suite howto videos faq  howto videos designed to reinforce some key aspects from customer training and to provide quick answers for some basic questions our goal is to maximize patient outcomes by increasing the adoption and utilization of new technology through customized peerdriven curriculum and a phased learning approach alcon will further establish itself as the global leader in eye care and as a trusted partner for hcps around the world click on a product to access the video library for that product these videos are approved for use in the united states lensx® laser system view videos veriontm image guided system view videos ora system® view videos wavelight® portfolio view videos home education  resources alcon surgical suite howto videos for security reasons and protection of your personal data your session timed out due to prolonged inactivity please log in again to access the system